The McPherson, Kansas site specializes in manufacturing sterile injectable medicines used daily in hospitals around the world. Those range from pain management treatments and medicines that enable sedation during surgery to life-saving antibiotics, critical blood pressure regulators and some of Pfizer’s first biosimilars.
The approximately 1,800 colleagues in McPherson support highly technical manufacturing capabilities including aseptic (sterile) manufacturing, lyophilization (freeze drying), biologics and biosimilars fill/finish, terminal sterilization and on-site stability testing.
McPherson produces medicines in several different presentations, including liquid and freeze-dried vials, pre-filled syringes and specialty syringe systems.
The McPherson site specializes in manufacturing sterile injectable medicines used daily in hospitals around the world.
The 230-acre site in Sanford, just south of the famed Research Triangle, is home to one of the largest U.S. biotechnology hubs.
The Rocky Mount site is one of the largest sterile injectable facilities in the world, with more than 1.4 million square feet of manufacturing space on 250 acres in Eastern North Carolina.
In Rochester, King Pharmaceuticals, a subsidiary of Pfizer, manufactures and packages penicillin, the only approved treatment for late stage syphilis.
With more than 100 years of rich history in innovation and manufacturing excellence, 19 products- including various vaccines, antibiotics, and oncology medicines, have been discovered, developed, and approved at the Pearl River, New York site.
Since 1982, the Middleton site has focused on the manufacture of biologics. The 83,000-square-foot facility isolates bovine thrombin, a naturally occurring enzyme which plays a critical role in rapid clotting (hemostasis) of blood.
The largest manufacturing site in the Pfizer network is located in Kalamazoo. This 1,300 acre facility manufactures active pharmaceutical ingredients (API), drug products (DP) and medical devices.
In Franklin, our 48,000-square-foot facility manufactures heparin active pharmaceutical ingredient (API).
